Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Gastpar

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Psychiatric Services (Washington, D.C.)|January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophreniaRebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Pharmacopsychiatry|May 16, 2017
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?Rebecca Schennach, Michael Obermeier, Florian Seemüller, et al.
International Journal of Methods in Psychiatric Research|July 17, 2015
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methodsRebecca Schennach, Hans-Jürgen Möller, Michael Obermeier, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic studyRebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 30, 2019
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Psychiatry Research|March 17, 2012
One-year functional outcomes of naturalistically treated patients with schizophreniaIlja Spellmann, Michael Riedel, Rebecca Schennach, et al.
Schizophrenia Research|May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depressionRebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studiesIlja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Psychiatric Services (Washington, D.C.)|January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophreniaRebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Pharmacopsychiatry|May 16, 2017
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?Rebecca Schennach, Michael Obermeier, Florian Seemüller, et al.
International Journal of Methods in Psychiatric Research|July 17, 2015
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methodsRebecca Schennach, Hans-Jürgen Möller, Michael Obermeier, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic studyRebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 30, 2019
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Psychiatry Research|March 17, 2012
One-year functional outcomes of naturalistically treated patients with schizophreniaIlja Spellmann, Michael Riedel, Rebecca Schennach, et al.
Schizophrenia Research|May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depressionRebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studiesIlja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Pageof 6